Skip to Main Content

UPDATED ADVISORY CONCERNING ELECTRONIC CIGARETTES, THE PRACTICE OF “VAPING,” “JUULING” AND USE OF OTHER ELECTRONIC NICOTINE DELIVERY SYSTEMS OR ENDS

Meningococcal Disease

Immediately Reportable!
Reportable by Providers and laboratories
Meningococcal Disease

Infectious agent:  Neisseria meningitidis

Description of illness:


Meningoccocal disease is a rare, vaccine-preventable infection caused by the bacteria Neisseria meningitidis. Invasive disease can present as an infection around the brain and spinal cord (meningitis), a blood stream infection (meningococcemia), or both. Acute meningitis symptoms typically include a sudden onset of fever, headache, and stiff neck, often accompanied by other symptoms such as nausea, vomiting, eye sensitivity to light (photophobia), and an altered mental status; testing of spinal fluid is required to distinguish N. meningitidis from other bacterial and viral causes of meningitis. Meningococcemia is characterized by an abrupt onset of fever and a rash, often associated with low blood pressure and shock, and can be fatal within hours. Meningococcemia occurs without meningitis in 5% - 20% of invasive meningococcal infections. Even with antibiotic treatment, about 1 in 10 people with meningococcal disease will die. About 1-2 in 10 survivors will have long-term disabilities, such as loss of limb(s), deafness, nervous system problems, or brain damage.